Persistence of antibodies 3 years after booster vaccination of adults with combined acellular pertussis, diphtheria and tetanus toxoids vaccine (Q50176350)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Persistence of antibodies 3 years after booster vaccination of adults with combined acellular pertussis, diphtheria and tetanus toxoids vaccine	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21945698

retrieved

26 February 2018

reference URL

http://europepmc.org/abstract/MED/21945698

title

Persistence of antibodies 3 years after booster vaccination of adults with combined acellular pertussis, diphtheria and tetanus toxoids vaccine (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21945698

retrieved

26 February 2018

reference URL

http://europepmc.org/abstract/MED/21945698

main subject

antibody

1 reference

based on heuristic

inferred from title

author name string

Wayde Weston

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21945698

retrieved

26 February 2018

reference URL

http://europepmc.org/abstract/MED/21945698

Marc Messier

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21945698

retrieved

26 February 2018

reference URL

http://europepmc.org/abstract/MED/21945698

Leonard R Friedland

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21945698

retrieved

26 February 2018

reference URL

http://europepmc.org/abstract/MED/21945698

Xiangfeng Wu

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21945698

retrieved

26 February 2018

reference URL

http://europepmc.org/abstract/MED/21945698

Barbara Howe

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21945698

retrieved

26 February 2018

reference URL

http://europepmc.org/abstract/MED/21945698

language of work or name

English

0 references

publication date

25 September 2011

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21945698

retrieved

26 February 2018

reference URL

http://europepmc.org/abstract/MED/21945698

number of pages

4

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21945698

retrieved

26 February 2018

reference URL

http://europepmc.org/abstract/MED/21945698

volume

29

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21945698

retrieved

26 February 2018

reference URL

http://europepmc.org/abstract/MED/21945698

issue

47

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21945698

retrieved

26 February 2018

reference URL

http://europepmc.org/abstract/MED/21945698

page(s)

8483-8486

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21945698

retrieved

26 February 2018

reference URL

http://europepmc.org/abstract/MED/21945698

cites work

The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.063

retrieved

7 January 2021

Immunogenicity and safety of a tetanus toxoid, reduced diphtheria toxoid and three-component acellular pertussis vaccine in adults 19-64 years of age.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.063

retrieved

7 January 2021

A decennial booster dose of reduced antigen content diphtheria, tetanus, acellular pertussis vaccine (Boostrix™) is immunogenic and well tolerated in adults

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.063

retrieved

7 January 2021

A randomized trial of two acellular pertussis vaccines (dTpa and pa) and a licensed diphtheria-tetanus vaccine (Td) in adults

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.063

retrieved

7 January 2021

Immunity to pertussis 5 years after booster immunization during adolescence

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.063

retrieved

7 January 2021

Decennial administration of a reduced antigen content diphtheria and tetanus toxoids and acellular pertussis vaccine in young adults

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.063

retrieved

7 January 2021

Identifiers

DOI

10.1016/J.VACCINE.2011.09.063

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21945698

retrieved

26 February 2018

reference URL

http://europepmc.org/abstract/MED/21945698

PubMed publication ID

21945698

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21945698

retrieved

26 February 2018

reference URL

http://europepmc.org/abstract/MED/21945698

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50176350&oldid=2244698529"